| 000 | 01708 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517172255.0 | ||
| 264 | 0 | _c20190930 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1435-1463 | ||
| 024 | 7 |
_a10.1007/s00702-017-1784-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIchinose, Hiroshi | |
| 245 | 0 | 0 |
_aAlterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neural transmission (Vienna, Austria : 1996) _c01 2018 |
||
| 300 |
_a45-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aMPTP Poisoning _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMacaca |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aParkinson Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aPteridines _xcerebrospinal fluid |
| 700 | 1 | _aInoue, Ken-Ichi | |
| 700 | 1 | _aArakawa, Shinobu | |
| 700 | 1 | _aWatanabe, Yuki | |
| 700 | 1 | _aKurosaki, Hiroki | |
| 700 | 1 | _aKoshiba, Shoko | |
| 700 | 1 | _aHustad, Eldbjorg | |
| 700 | 1 | _aTakada, Masahiko | |
| 700 | 1 | _aAasly, Jan O | |
| 773 | 0 |
_tJournal of neural transmission (Vienna, Austria : 1996) _gvol. 125 _gno. 1 _gp. 45-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00702-017-1784-x _zAvailable from publisher's website |
| 999 |
_c27521111 _d27521111 |
||